Trinity Biotech (TRIB) Shares Outstanding (2017 - 2025)

Trinity Biotech's Shares Outstanding history runs 9 years deep, the most recent figure standing at $374.2 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 4.18% year-over-year to $374.2 million; the TTM figure through Dec 2025 stood at $374.2 million (up 4.18% YoY), while the FY2025 annual figure was $374.2 million, up 4.18% from the prior year.
• Shares Outstanding came in at $374.2 million for Q4 2025 at Trinity Biotech, up from $359.2 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $374.2 million in Q4 2025 to a low of $83.6 million in Q4 2021.
• A 5-year average of $224.5 million and a median of $153.3 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding changed 0.0% in 2021 and jumped 134.29% in 2024, its largest moves.
• Trinity Biotech's Shares Outstanding stood at $83.6 million in 2021, then surged by 82.32% to $152.4 million in 2022, then grew by 0.58% to $153.3 million in 2023, then soared by 134.29% to $359.2 million in 2024, then gained by 4.18% to $374.2 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $374.2 million, $359.2 million, and $153.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison